CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Lake Mary, Florida, United States and 71 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Orlando, Florida, United States and 75 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Orlando, Florida, United States and 215 other locations
by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...
Phase 1, Phase 2
Orlando, Florida, United States and 9 other locations
Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The secondary objectives are to characterize t...
Phase 1
Lake Mary, Florida, United States and 4 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Orlando, Florida, United States and 37 other locations
of ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refra...
Phase 1, Phase 2
Orlando, Florida, United States and 22 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Lake Mary, Florida, United States and 55 other locations
The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; par...
Phase 3
Lakeland, Florida, United States and 179 other locations
Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this dise...
Phase 3
Orlando, Florida, United States and 219 other locations
Clinical trials
Research sites
Resources
Legal